Study of Vonoprazan-based triple theary for eradication of helicobacter pylori

Study of Vonoprazan-based triple theary for eradication of helicobacter pylori - Eradication with Vonoprazan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022846

Enrollment

2000

Registered

2016-07-01

Start date

2015-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastritis with helicobacter pylori infection

Interventions

Vonoprazan 40mg/day 7days Proton pump inhibitor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with helicobacter pylori infection

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Success rate of the eradication therapy after one month later by urea breath test	—

Secondary

Measure	Time frame
Mortality and morbidity of the eradication therapy	—

Countries

Japan

Contacts

Public ContactRyuzo Murai

Onaka Clinic Department of gastroenterology

murai@m-onaka.com042-644-1127

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026